Parkman Healthcare Partners LLC acquired a new position in shares of Nuvalent, Inc. (NASDAQ:NUVL – Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 59,867 shares of the company’s stock, valued at approximately $4,406,000. Parkman Healthcare Partners LLC owned about 0.10% of […]
Avoro Capital Advisors LLC raised its holdings in Ascendis Pharma A/S (NASDAQ:ASND – Free Report) by 2.3% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The fund owned 3,755,555 shares of the biotechnology company’s stock after buying an additional 85,555 shares during the quarter. Ascendis Pharma A/S […]
Bellevue Group AG decreased its position in Verona Pharma plc (NASDAQ:VRNA – Free Report) by 1.9% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 839,996 shares of the company’s stock after selling 16,362 shares during the period. Bellevue Group AG owned about 1.05% of Verona Pharma […]
Seven Eight Capital LP purchased a new stake in shares of Ascendis Pharma A/S (NASDAQ:ASND – Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 18,636 shares of the biotechnology company’s stock, valued at approximately $2,347,000. A number of […]
Rhenman & Partners Asset Management AB lowered its holdings in Cytokinetics, Incorporated (NASDAQ:CYTK – Free Report) by 25.0% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 149,912 shares of the biopharmaceutical company’s stock after selling 50,088 shares during the quarter. Rhenman & Partners Asset […]
Rafferty Asset Management LLC lifted its holdings in shares of Cytokinetics, Incorporated (NASDAQ:CYTK – Free Report) by 6.6% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 263,275 shares of the biopharmaceutical company’s stock after purchasing an additional 16,353 shares during the quarter. Rafferty Asset Management LLC’s […]
Immunocore Holdings plc (NASDAQ:IMCR – Get Free Report) has received a consensus rating of “Moderate Buy” from the fifteen ratings firms that are currently covering the firm, Marketbeat reports. Two equities research analysts have rated the stock with a hold rating and thirteen have issued a buy rating on the company. The average 1 year […]
Harvest Investment Services LLC bought a new stake in Nuvalent, Inc. (NASDAQ:NUVL – Free Report) in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm bought 4,500 shares of the company’s stock, valued at approximately $331,000. A number of other hedge funds also recently added to or […]
Cantor Fitzgerald reissued their overweight rating on shares of Disc Medicine (NASDAQ:IRON – Free Report) in a report issued on Tuesday morning, Benzinga reports. They currently have a $85.00 target price on the stock. IRON has been the subject of a number of other reports. Wedbush reaffirmed an outperform rating and set a $43.00 price […]
Immunocore Holdings plc (NASDAQ:IMCR – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the fifteen analysts that are presently covering the stock, Marketbeat Ratings reports. Two investment analysts have rated the stock with a hold rating and thirteen have issued a buy rating on the company. The average 1-year price objective […]